Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week
for 24 weeks
// //

Oil prices on Monday jumped to their highest in over two months on positive early results on a potential coronavirus vaccine, optimism about a resumption in economic activity and signs producers were following through on planned output reductions.

Brent futures for July delivery rose $2.31, or 7.1%, to $34.81 a barrel, while U.S. West Texas Intermediate (WTI) crude rose $2.39, or 8.1%, to $31.82.

That was the highest settles for Brent and WTI since March 11, just a few days after prices started to collapse following the failure of a production cut agreement between the Organization of the Petroleum Exporting Countries (OPEC) and Russia, a group known as OPEC+.

Story continues below advertisement

“It has taken WTI over two months to basically clean up the wreckage from the March (OPEC+) meeting,” said Bob Yawger, director of energy futures at Mizuho in New York.

In the first half of May, OPEC+ has cut oil exports sharply, companies that track the shipments said, suggesting a strong start in complying with a new production cut agreement.

OPEC+ agreed to cut supply by a record 9.7 million barrels per day (bpd) from May 1. Saudi Arabia, the world’s top exporter, announced last week it would cut an additional 1 million barrels per day in June.

The rally in the June WTI contract, which will expire on Tuesday, suggested last month’s historic plunge to negative-$40 a barrel would not be repeated.

July WTI was the more actively traded U.S. futures contract with volumes in the second-month contract outpacing the front-month for several days now. The July contract closed up 7.2% to $31.65.

In the United States, the phased reopening of business and social life gained traction with more Americans emerging from coronavirus lockdowns and stock markets rising on early test results of a potential vaccine.

Early data from Moderna Inc’s COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on Monday.

Story continues below advertisement

Summer weather is enticing the rest of the world to emerge from coronavirus lockdowns too.

Shops and restaurants were reopening in Italy on Monday, while other centres of the outbreak such Spain and Portugal will gradually lift restrictions.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies